Salubris Biotherapeuticsinc Salubrisbiois A Clinical Stage Biotechnology Company Based In Gaithersburgmarylandfounded In August 2016 As A Subsidiary Of Shenzhen Salubris Pharmaceuticals Coltd The Company Focuses On Discovering And Developing Innovative Antibody And Protein Based Therapeutics For Unmet Medical Needs In Cardiovascular Diseasescancerand Neurodegenerative Diseases Salubrisbio Is Dedicated To Advancing Its Pipeline Of Complex Biologicswhich Includes Jk07An Antibody Based Nrg 1 Fusion Protein In Phase 1 Trials For Heart Failurejk08An Investigational Il15 Ctla4 Antibody Fusion For Solid Tumorsand Jk06A Biparatopic Antibody Drug Conjugate Targeting A Known Tumor Antigenthe Company Aims To Deliver First In Class Biologics That Enhance The Health And Quality Of Life For Patients With Complicated Diseasesled By Ceo Sam Murphythe Team Comprises Industry Experts Committed To The Development Of Novel Therapies
